Anzeige
Mehr »
Login
Mittwoch, 28.07.2021 Börsentäglich über 12.000 News von 669 internationalen Medien
Countdown: Die derzeit größte Kurswette mit Ansage!?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0LA5K ISIN: SE0000872095 Ticker-Symbol: B6E 
Tradegate
28.07.21
21:44 Uhr
16,495 Euro
+0,350
+2,17 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
SWEDISH ORPHAN BIOVITRUM AB Chart 1 Jahr
5-Tage-Chart
SWEDISH ORPHAN BIOVITRUM AB 5-Tage-Chart
RealtimeGeldBriefZeit
16,31016,53022:00
16,42016,57521:56

Aktuelle News zur SWEDISH ORPHAN BIOVITRUM Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
SWEDISH ORPHAN BIOVITRUM Aktie jetzt für 0€ handeln
DoSwedish Orphan Biovitrum AB (publ) (BIOVF) CEO Guido Oelkers on Q2 2021 Results - Earnings Call Transcript5
21.07.Swedish Orphan Biovitrum AB (publ) 2021 Q2 - Results - Earnings Call Presentation3
21.07.Swedish Orphan Biovitrum AB reports Q2 results5
21.07.Drugmaker Sobi profit tops forecasts, sees markets recovering7
21.07.SOBI Q2 EBITA SEK 922 Million vs. Estimate SEK 830 Million120(PLX AI) - SOBI Q2 revenue SEK 3,211 million vs. estimate SEK 3,034 million.• Outlook FY revenue SEK 14,000-15,000 million• Outlook FY EBITA margin 30-35%
► Artikel lesen
21.07.SWEDISH ORPHAN BIOVITRUM AB: Sobi publishes report for the second quarter 20216
20.07.SWEDISH ORPHAN BIOVITRUM AB: The Board of directors exercises authorisation for repurchase of shares for the purpose of securing the company's commitments under the incentive programme3
19.07.EU evaluates Sobi arthritis drug to treat COVID-19 with pneumonia5
08.07.Invitation - Presentation of Sobi's Q2 2021 results202STOCKHOLM, July 8, 2021 /PRNewswire/ -- On 21 July, at 08:00 CEST, Swedish Orphan Biovitrum AB (publ) (Sobi) will publish its report for the second quarter 2021. Investors, financial analysts...
► Artikel lesen
07.07.Sobi to present data at the ISTH 2021 within rare haematology diseases191STOCKHOLM, July 7, 2021 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi) presents data at the virtual ISTH 2021, the 29th Congress of the International Society on Thrombosis and...
► Artikel lesen
29.06.SOBI Rises 2% After Kepler Initiates with Buy Recommendation229(PLX AI) - SOBI shares rose 2% in early trading after Kepler Cheuvreux initiated coverage with a buy recommendation. • Price target SEK 180 implies 18% upside• SOBI's late-stage pipeline will drive...
► Artikel lesen
29.06.Swedish Orphan Initiated with Buy at Kepler Cheuvreux216(PLX AI) - Price target SEK 180.
► Artikel lesen
01.06.Sobi at EHA virtual congress 2021: focus on results in PNH and treatment for ITP246STOCKHOLM, June 1, 2021 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi) will present data at the EHA (European Haematology Association) virtual congress, 9-17 June 2021, highlighting...
► Artikel lesen
25.05.Apellis-Sobi Partnered Pegcetacoplan Shows Clinically Meaningful Improvements in Rare Blood Disorder Study7
11.05.Swedish Orphan Biovitrum AB (publ) (BIOVF) CEO Guido Oelkers on Q1 2021 Results - Earnings Call Transcript11
04.05.SWEDISH ORPHAN BIOVITRUM AB: Bulletin from Swedish Orphan Biovitrum's (";Sobi") Annual General Meeting (AGM)10
04.05.Swedish Orphan Biovitrum AB reports Q1 results16
03.05.SWEDISH ORPHAN BIOVITRUM AB: Sobi and Hellenic Institute for the Study of Sepsis: anakinra improved overall clinical outcomes by 64% in hospitalised patients with COVID-19 pneumonia8
26.04.Invitation - Presentation of Sobi's Q1 2021 results277STOCKHOLM, April 26, 2021 /PRNewswire/ -- On 4 May, at 08:00 CEST, Swedish Orphan Biovitrum AB (publ) (Sobi) will publish its report for the first quarter 2021. Investors, financial analysts...
► Artikel lesen
07.04.Ionis lays off majority of Akcea staff, expands Sobi Tegsedi deal31
Seite:  Weiter >>
31 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1